Rieder M J, Uetrecht J, Shear N H, Spielberg S P
Department of Paediatrics, Faculty of Medicine, Hospital for Sick Children, Toronto, Ontario, Canada.
J Pharmacol Exp Ther. 1988 Feb;244(2):724-8.
Among the most serious side effects of sulfonamides are hypersensitivity reactions, the pathogenesis of which has been suggested to be mediated by reactive metabolites. We have previously demonstrated dose-related covalent binding and toxicity of reactive intermediates of sulfonamides generated by a murine hepatic microsomal activating system. We hypothesized that hydroxylamine (H/A) metabolites might be likely candidates for mediating such toxicity; accordingly, we synthesized chemically the H/As of sulfadiazine and sulfamethoxazole. Synthesis was performed using 4-nitrobenzenesulfonyl chloride and either 2-aminopyrimidine or 3-amino-5-methylisoxazole, respectively, as starting materials. The resulting nitro derivatives were reduced to the corresponding H/A with hydrogen in the presence of a poisoned platinum catalyst. After synthesis and purification, toxicity of the H/As to lymphocytes of normal volunteers was evaluated using three cytotoxicity assays: 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide dye conversion, trypan blue dye exclusion and propidium iodide dye exclusion. The H/As of sulfadiazine and sulfamethoxazole displayed dose-related toxicity. 1.6 mM sulfadiazine H/A produced 82% cell death, whereas 400 microM sulfamethoxazole H/A produced 62% cell death; the parent sulfonamides were not toxic to cells. The toxicity of sulfamethoxazole H/A was decreased by coincubation with glutathione or N-acetylcysteine; there was a 47% decrease in toxicity when coincubated with 100 microM glutathione, whereas there was a 55% decrease displayed when coincubation was done with 500 microM N-acetylcysteine. H/A metabolites of the sulfonamides or their nitroso derivatives, normally detoxified by conjugation to glutathione, may be the proximate toxins mediating sulfonamide hypersensitivity.
磺胺类药物最严重的副作用之一是过敏反应,其发病机制被认为是由反应性代谢产物介导的。我们之前已经证明了由小鼠肝脏微粒体激活系统产生的磺胺类药物反应性中间体的剂量相关共价结合和毒性。我们推测羟胺(H/A)代谢产物可能是介导这种毒性的潜在候选物;因此,我们化学合成了磺胺嘧啶和磺胺甲恶唑的H/A。分别使用4-硝基苯磺酰氯和2-氨基嘧啶或3-氨基-5-甲基异恶唑作为起始原料进行合成。在中毒铂催化剂存在下,用氢气将所得硝基衍生物还原为相应的H/A。合成和纯化后,使用三种细胞毒性试验评估H/A对正常志愿者淋巴细胞的毒性:3-(4,5-二甲基噻唑-2-基)-2,5-二苯基溴化四氮唑染料转化、台盼蓝染料排斥和碘化丙啶染料排斥。磺胺嘧啶和磺胺甲恶唑的H/A显示出剂量相关的毒性。1.6 mM磺胺嘧啶H/A导致82%的细胞死亡,而400 microM磺胺甲恶唑H/A导致62%的细胞死亡;母体磺胺类药物对细胞无毒。磺胺甲恶唑H/A与谷胱甘肽或N-乙酰半胱氨酸共同孵育时毒性降低;与100 microM谷胱甘肽共同孵育时毒性降低47%,而与500 microM N-乙酰半胱氨酸共同孵育时毒性降低55%。磺胺类药物的H/A代谢产物或其亚硝基衍生物通常通过与谷胱甘肽结合而解毒,可能是介导磺胺类药物过敏反应的直接毒素。